While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...

Novo Nordisk ) is going big in Brazil. The drugmaker behind Ozempic and Wegovy just dropped a $1.09 billion investment to ...

Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk , nearly doubled annual income and investment returns to a record 8 billion euros ($8.66 billion) in 2024, it said on ...

Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...

The new plant will be one of the largest manufacturing investments in Novo Nordisk’s history and will add 1.4 million sq ft of production space for aseptic manufacturing and finished production ...

It subsequently sold three Catalent manufacturing plants to Novo Nordisk for $11 billion to boost Wegovy production. However, total assets under management dropped slightly to 142 billion euros in ...

Stocks in drugmakers sold off globally after President Trump said tariffs on pharmaceutical imports will be unveiled shortly, ...

Novavax NVAX announced that it has agreed to sell its manufacturing facility ... sale opportunities for the plant to save operating costs. If the deal with Novo Nordisk goes through, the company ...

The Novo Nordisk Foundation is funding the creation of a cell therapy development and manufacturing facility in Denmark with one of the largest investments in the sector in Europe. The Foundation ...

The chief executives of several pharmaceutical giants based in Ireland, such as Pfizer, Eli Lilly, and MSD, said there was a ...